Literature DB >> 16328203

[Quality of life in patients with chronic rhinosinusitis: validation of the Sino-Nasal Outcome Test-20 German Adapted Version].

I Baumann1, G Blumenstock, H DeMaddalena, J F Piccirillo, P K Plinkert.   

Abstract

BACKGROUND: No validated German instrument for measuring health-related quality of life (QOL) in patients with chronic rhinosinusitis (CRS) has been available to date.
METHODS: The Sino-Nasal Outcome Test-20 German Adapted Version (SNOT-20 GAV) is a translated and adapted version of SNOT-20. To validate this instrument, we evaluated its reliability, validity and sensitivity. SNOT-20 GAV was completed by 163, 123, and 82 patients at the initial visit and at 3 months and 1 year after treatment commencement, respectively.
RESULTS: Cronbach's alpha indicated good internal consistency. Test-retest scores in 38 patients were highly correlated. Discrimination validity was demonstrated by a comparison with healthy controls. Sensitivity to change showed medium to large effects.
CONCLUSIONS: SNOT-20 GAV is the first reliable, validated and sensitive German instrument for measuring health-related QOL in patients with CRS.

Entities:  

Mesh:

Year:  2007        PMID: 16328203     DOI: 10.1007/s00106-005-1347-6

Source DB:  PubMed          Journal:  HNO        ISSN: 0017-6192            Impact factor:   1.284


  13 in total

1.  The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection.

Authors:  J E Ware; C D Sherbourne
Journal:  Med Care       Date:  1992-06       Impact factor: 2.983

Review 2.  [Sinusitis. An illness to be taken seriously].

Authors:  J Pade
Journal:  HNO       Date:  2005-05       Impact factor: 1.284

3.  [Concepts for measuring quality of life in patients with chronic sinusitis].

Authors:  S Maune; H Rudert; M C Heissenberg; C Schmidt; S Eggers; K Landmann; T Küchler
Journal:  Laryngorhinootologie       Date:  1999-09       Impact factor: 1.057

4.  The health impact of chronic recurrent rhinosinusitis in children.

Authors:  M J Cunningham; J M Cunningham; E J Chiu; J M Landgraf; R E Gliklich
Journal:  Arch Otolaryngol Head Neck Surg       Date:  2000-11

5.  The development of a General Nasal Patient Inventory.

Authors:  S A Douglas; A H Marshall; D Walshaw; A K Robson; J A Wilson
Journal:  Clin Otolaryngol Allied Sci       Date:  2001-10

6.  Reliability and validity of a new measure of patient satisfaction with out of hours primary medical care in the United Kingdom: development of a patient questionnaire.

Authors:  R K McKinley; T Manku-Scott; A M Hastings; D P French; R Baker
Journal:  BMJ       Date:  1997-01-18

Review 7.  Rhinosinusitis: Establishing definitions for clinical research and patient care.

Authors:  Eli O Meltzer; Daniel L Hamilos; James A Hadley; Donald C Lanza; Bradley F Marple; Richard A Nicklas; Claus Bachert; James Baraniuk; Fuad M Baroody; Michael S Benninger; Itzhak Brook; Badrul A Chowdhury; Howard M Druce; Stephen Durham; Berrylin Ferguson; Jack M Gwaltney; Michael Kaliner; David W Kennedy; Valerie Lund; Robert Naclerio; Ruby Pawankar; Jay F Piccirillo; Patricia Rohane; Ronald Simon; Raymond G Slavin; Alkis Togias; Ellen R Wald; S James Zinreich
Journal:  Otolaryngol Head Neck Surg       Date:  2004-12       Impact factor: 3.497

8.  The development of the Rhinosinusitis Disability Index.

Authors:  M S Benninger; B A Senior
Journal:  Arch Otolaryngol Head Neck Surg       Date:  1997-11

9.  Medical management of sinusitis.

Authors:  M Kaliner
Journal:  Am J Med Sci       Date:  1998-07       Impact factor: 2.378

Review 10.  Quality of life measurement: bibliographic study of patient assessed health outcome measures.

Authors:  Andrew Garratt; Louise Schmidt; Anne Mackintosh; Ray Fitzpatrick
Journal:  BMJ       Date:  2002-06-15
View more
  21 in total

1.  [Botulinum toxin for the treatment of secretory disorders of the head and neck area].

Authors:  A Steffen
Journal:  HNO       Date:  2012-06       Impact factor: 1.284

2.  Quality of life in functional rhinoplasty: rhinoplasty outcomes evaluation German version (ROE-D).

Authors:  Olcay Cem Bulut; Peter K Plinkert; Frank Wallner; Ingo Baumann
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-02-10       Impact factor: 2.503

3.  [Inoperable nasoseptal defects: closure with custom-made silastic prostheses].

Authors:  A Neumann; M Schneider; C Tholen; A Minovi
Journal:  HNO       Date:  2010-04       Impact factor: 1.284

4.  [Research on quality of life in ear, nose, and throat medicine].

Authors:  I Baumann
Journal:  HNO       Date:  2009-09       Impact factor: 1.284

Review 5.  Danger points, complications and medico-legal aspects in endoscopic sinus surgery.

Authors:  W Hosemann; C Draf
Journal:  GMS Curr Top Otorhinolaryngol Head Neck Surg       Date:  2013-12-13

6.  [Subjective patient satisfaction after nasal septumplasty].

Authors:  J Lindemann; A von Bomhard; T Hoffmann; M Scheithauer; A-S Grossi; F Sommer; S Ott
Journal:  HNO       Date:  2017-11       Impact factor: 1.284

7.  Development, reliability, validity and sensitivity of the Sino-Nasal Outcome Test for Neurosurgery (SNOT-NC).

Authors:  Yahya Ahmadipour; Oliver Müller; Ilonka Kreitschmann-Andermahr; Stefan Mattheis; Ulrich Sure; Bernd-Otto Hütter
Journal:  Eur Arch Otorhinolaryngol       Date:  2019-09-26       Impact factor: 2.503

8.  [Development of a grading scale for the Sino-Nasal Outcome Test-20 German Adapted Version (SNOT-20 GAV)].

Authors:  I Baumann; P K Plinkert; H De Maddalena
Journal:  HNO       Date:  2008-08       Impact factor: 1.284

Review 9.  [Validated instruments to measure quality of life in patients with chronic rhinosinusitis].

Authors:  I Baumann
Journal:  HNO       Date:  2009-09       Impact factor: 1.284

10.  Evaluation of the application of rhino-septal splints in endoscopic transsphenoidal skull base surgery.

Authors:  Anke Schlüter; Yahya Ahmadipour; Trutz Vogelsang; Ilonka Kreitschmann-Andermahr; Bernadette Kleist; Patrick Weller; Laura Holtmann; Stefan Mattheis; Stephan Lang; Christoph Bergmann; Oliver Mueller
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-06-30       Impact factor: 2.503

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.